Odronextamab
RG_21-124
Phase 3 small_molecule active
Quick answer
Odronextamab for B-cell Non Hodgkin Lymphoma is a Phase 3 program (small_molecule) at ADC Therapeutics SA with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ADC Therapeutics SA
- Indication
- B-cell Non Hodgkin Lymphoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active